Natural killer cells: biology and clinical use in cancer therapy.
about
Angiocentric lesions of the head and neckNK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells.
P2860
Natural killer cells: biology and clinical use in cancer therapy.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Natural killer cells: biology and clinical use in cancer therapy.
@ast
Natural killer cells: biology and clinical use in cancer therapy.
@en
type
label
Natural killer cells: biology and clinical use in cancer therapy.
@ast
Natural killer cells: biology and clinical use in cancer therapy.
@en
prefLabel
Natural killer cells: biology and clinical use in cancer therapy.
@ast
Natural killer cells: biology and clinical use in cancer therapy.
@en
P1476
Natural killer cells: biology and clinical use in cancer therapy.
@en
P2093
William H D Hallett
William J Murphy
P577
2004-02-01T00:00:00Z